πŸ‡ΊπŸ‡Έ FDA
Patent

US 10792276

Urolithins as immune response enhancers

granted A61KA61K2039/55A61K2039/55511

Quick answer

US patent 10792276 (Urolithins as immune response enhancers) held by Amazentis SA expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amazentis SA
Grant date
Tue Oct 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/55, A61K2039/55511, A61K31/335, A61K31/37